Literature DB >> 29528180

Randomized trial comparing caregiver-only family-focused treatment to standard health education on the 6-month outcome of bipolar disorder.

Deborah A Perlick1,2, Carlos Jackson1,2, Savannah Grier1,2, Brittney Huntington1,2, Andrew Aronson2, Xiaodong Luo1,2, David J Miklowitz3.   

Abstract

OBJECTIVES: Caregivers of people with bipolar disorder often have depression and health problems. This study aimed to evaluate the sustained effects of a 12-15 week psychoeducational intervention on the health and mental health of caregivers of persons with bipolar disorder. We also evaluated the effects of the intervention on patients' mood symptoms over 6 months post-treatment.
METHODS: Caregivers of 46 persons with bipolar disorder were randomized to 12-15 weeks of a caregiver-only adaptation of family-focused treatment (FFT), in which caregivers were instructed on self-care strategies and ways to assist the patient in managing the illness, or to 8-12 sessions of standard health education. Independent evaluators assessed caregivers' depression and physical health and patients' mood symptoms before treatment, immediately after the treatment, and at 6 months post-treatment.
RESULTS: Randomization to FFT was associated with greater decreases in depression for both caregivers and patients over a 6-month follow-up period post-treatment. Reductions in patients' depression scores over 6 months post-treatment were mediated by reductions in caregivers' depression scores (z = -2.74, P < .01).
CONCLUSIONS: Interventions that are effective in reducing mood symptoms and improving health behavior in caregivers may have important health and mental health benefits for patients with bipolar disorder. Specifically, a treatment focused on caregiver education about bipolar disorder and the need for the caregiver to attend to his/her own health and mental health can benefit patients, even without their direct participation.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bipolar disorder; family depression; family education; patient bipolar mood symptoms

Mesh:

Year:  2018        PMID: 29528180     DOI: 10.1111/bdi.12621

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  5 in total

1.  A Longitudinal Study of Family Functioning in Offspring of Parents Diagnosed With Bipolar Disorder.

Authors:  Amit Shalev; John Merranko; Tina Goldstein; David J Miklowitz; David Axelson; Benjamin I Goldstein; David Brent; Kelly Monk; Mary Beth Hickey; Danella M Hafeman; Dara Sakolsky; Rasim Diler; Boris Birmaher
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2018-12-19       Impact factor: 8.829

2.  Sixth Kraepelin Symposium-Understanding and Treating Cognitive Impairment and Depression in Schizophrenia and Affective Disorders.

Authors:  Schaub Annette; Falkai Peter
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306

3.  Community-based social interventions for people with severe mental illness: a systematic review and narrative synthesis of recent evidence.

Authors:  Helen Killaspy; Carol Harvey; Catherine Brasier; Lisa Brophy; Priscilla Ennals; Justine Fletcher; Bridget Hamilton
Journal:  World Psychiatry       Date:  2022-02       Impact factor: 49.548

4.  Longitudinal relationship between maternal distress and pediatric mood symptoms in youth with mood disorders.

Authors:  Marc J Weintraub; Christopher D Schneck; Manpreet K Singh; Patricia D Walshaw; Kiki D Chang; Aimee E Sullivan; David J Miklowitz
Journal:  J Psychiatr Res       Date:  2021-10-26       Impact factor: 4.791

5.  Effects of Family-Focused Therapy vs Enhanced Usual Care for Symptomatic Youths at High Risk for Bipolar Disorder: A Randomized Clinical Trial.

Authors:  David J Miklowitz; Christopher D Schneck; Patricia D Walshaw; Manpreet K Singh; Aimee E Sullivan; Robert L Suddath; Marcy Forgey Borlik; Catherine A Sugar; Kiki D Chang
Journal:  JAMA Psychiatry       Date:  2020-05-01       Impact factor: 21.596

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.